Toxicology of FK506 in the cynomolgus monkey: a clinical, biochemical, and histopathological study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Transplant International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-642-77423-2_132PMID 14621844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FK506‐INDUCED IMPAIRMENT OF GLUCOSE METABOLISM IN THE PRIMATE—STUDIES IN PANCREATIC TRANSPLANT RECIPIENTS AND IN NONTRANSPLANTED ANIMALS

  1992cited by this paper
• B-cell lymphoma in transplanted liver

  1991cited by this paper
• B‐cell lymphoma in transplanted liver: Clinical, histological and radiological manifestations

  1991cited by this paper
• Measurement of FK 506 by HPLC and isolation and characterization of its metabolites.

  1991cited by this paper
• FK 506: monitoring in plasma or in whole blood?

  1991cited by this paper
• Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels.

  1991cited by this paper
• Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.

  1991cited by this paper
• A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.

  1990cited by this paper
• Toxicologic evaluation of FK 506.

  1990cited by this paper
• Pancreaticoduodenal allotransplantation with FK 506 in the dog.

  1990cited by this paper
• Assay of FK 506 in plasma.

  1990cited by this paper
• The mechanism of action of FK 506.

  1990cited by this paper
• Pancreaticoduodenal allotransplantation with FK 506 in the cynomolgus monkey.

  1990cited by this paper
• The effect of FK 506 on small intestine allotransplantation in the rat.

  1990cited by this paper
• Pancreaticoduodenal allotransplantation with cyclosporine and FK506.

  1989cited by this paper
• Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival.

  1989cited by this paper
• Orthotopic liver transplantation in rats receiving FK506.

  1989cited by this paper
• LIMB ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH FK506: I. REVERSAL OF REJECTION AND INDEFINITE SURVIVAL

  1989cited by this paper
• PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506

  1988cited by this paper
• Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

  1988cited by this paper
• Structure of FK506, a novel immunosuppressant isolated from Streptomyces

  1987cited by this paper
• Effect of FK-506 on human mixed lymphocyte reaction in vitro.

  1987cited by this paper
• Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

  1987cited by this paper
• Cancers following cyclosporine therapy.

  1987cited by this paper
• Cancers following cyclosporine therapy.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

  1987cited by this paper
• THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS.

  1987cited by this paper
• STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG‐TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATS

  1987cited by this paper
• Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

  1987cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

  1987cited by this paper
• A highly sensitive method to assay FK-506 levels in plasma.

  1987cited by this paper
• Kidney transplantation in the dog receiving FK-506.

  1987cited by this paper
• Orthotopic liver transplantation in dogs receiving FK-506.

  1987cited by this paper
• FK-506 in experimental renal allografts.

  1987cited by this paper
• In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.

  1987cited by this paper
• The oral dosage form of FK-506.

  1987cited by this paper
• Observations about FK-506 in primates.

  1987cited by this paper
• Immunologic control of hemopoiesis: implications for quality of the graft after allogeneic bone marrow transplantation.

  1987cited by this paper
• Toxicology of FK-506 in the Lewis rat.

  1987cited by this paper

• Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo

  2020cites this paper
• Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations

  2017cites this paper
• Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches

  2016cites this paper
• Role of Oxidative Stress in Drug-Induced Kidney Injury

  2016cites this paper
• Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy.

  2012cites this paper
• Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.

  2011cites this paper
• Upregulation of CD59: Potential Mechanism of Accommodation in a Large Animal Model

  2009cites this paper
• Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys.

  2008cites this paper
• Topical therapy II: retinoids, immunomodulators, and others

  2008cites this paper
• Topical Calcineurin Inhibitors in Pediatric Atopic Dermatitis

  2007cites this paper
• Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

  2007cites this paper
• Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients

  2007cites this paper
• Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

  2007cites this paper
• Immunosuppression in nonhuman primates

  2006cites this paper
• A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

  2006cites this paper
• Immunomodulation and Safety of Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis

  2005cites this paper
• Liver transplantation and bile analysis: a parallel evolution.

  1998cites this paper
• Update of tacrolimus in pancreas transplantation

  1997cites this paper
• Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus.

  1997cites this paper
• FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

  1993cites this paper